Ashley M Sacks, DPT | |
135 S Wakea Ave Ste 112, Kahului, HI 96732-1385 | |
(808) 280-7711 | |
(808) 442-0690 |
Full Name | Ashley M Sacks |
---|---|
Gender | Female |
Speciality | Physical Therapist |
Location | 135 S Wakea Ave Ste 112, Kahului, Hawaii |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1013177245 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
225100000X | Physical Therapist | 7009403-2401 (Utah) | Secondary |
225100000X | Physical Therapist | PT-4798 (Hawaii) | Primary |
Provider Name | Joanna Clarice Kahn |
---|---|
Provider Type | Practitioner - Physical Therapist In Private Practice |
Provider Identifiers | NPI Number: 1528272515 PECOS PAC ID: 7810185832 Enrollment ID: I20101217000133 |
News Archive
The FDA has granted Cytori Therapeutics 510(k) marketing clearance for its PureGraft™ System. Cytori will now launch the first and only device in the United States cleared for aesthetic body contouring using autologous fat. PureGraft™ allows a patient's own fat tissue to rapidly be prepared in approximately 15 minutes for re-injection back into the same patient for aesthetic contouring.
A study led by Russell R. Russo, MD, a third-year Orthopaedic Surgery resident at LSU Health Sciences Center New Orleans School of Medicine, has identified a new source of life-threatening necrotizing fasciitis - "bath salts."
MedGenesis Therapeutix Inc. ("MedGenesis"), a biopharmaceutical company developing and commercializing innovative treatments for patients with serious central nervous system (CNS) diseases, announced today that it has successfully entered into an agreement with Amgen Inc. ("Amgen"), granting MedGenesis an exclusive, worldwide license for glial cell line-derived neurotrophic factor (GDNF) protein in CNS and non-CNS indications, subject to the rights of a co-exclusive licensee for CNS indications in certain countries, as further described below.
Main Finding(s): Minority women were more likely to have aggressive subtypes of breast cancer and were more likely to receive non-guideline concordant treatment when compared with non-Hispanic white women.
› Verified 4 days ago
Provider Name | University Of Utah Adult Services |
---|---|
Provider Type | Part B Supplier - Clinic/group Practice |
Provider Identifiers | NPI Number: 1114321981 PECOS PAC ID: 0941525273 Enrollment ID: O20150209001683 |
News Archive
The FDA has granted Cytori Therapeutics 510(k) marketing clearance for its PureGraft™ System. Cytori will now launch the first and only device in the United States cleared for aesthetic body contouring using autologous fat. PureGraft™ allows a patient's own fat tissue to rapidly be prepared in approximately 15 minutes for re-injection back into the same patient for aesthetic contouring.
A study led by Russell R. Russo, MD, a third-year Orthopaedic Surgery resident at LSU Health Sciences Center New Orleans School of Medicine, has identified a new source of life-threatening necrotizing fasciitis - "bath salts."
MedGenesis Therapeutix Inc. ("MedGenesis"), a biopharmaceutical company developing and commercializing innovative treatments for patients with serious central nervous system (CNS) diseases, announced today that it has successfully entered into an agreement with Amgen Inc. ("Amgen"), granting MedGenesis an exclusive, worldwide license for glial cell line-derived neurotrophic factor (GDNF) protein in CNS and non-CNS indications, subject to the rights of a co-exclusive licensee for CNS indications in certain countries, as further described below.
Main Finding(s): Minority women were more likely to have aggressive subtypes of breast cancer and were more likely to receive non-guideline concordant treatment when compared with non-Hispanic white women.
› Verified 4 days ago
Provider Name | Ihc Health Services Inc |
---|---|
Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
Provider Identifiers | NPI Number: 1033822085 PECOS PAC ID: 1850209420 Enrollment ID: O20230627000064 |
News Archive
The FDA has granted Cytori Therapeutics 510(k) marketing clearance for its PureGraft™ System. Cytori will now launch the first and only device in the United States cleared for aesthetic body contouring using autologous fat. PureGraft™ allows a patient's own fat tissue to rapidly be prepared in approximately 15 minutes for re-injection back into the same patient for aesthetic contouring.
A study led by Russell R. Russo, MD, a third-year Orthopaedic Surgery resident at LSU Health Sciences Center New Orleans School of Medicine, has identified a new source of life-threatening necrotizing fasciitis - "bath salts."
MedGenesis Therapeutix Inc. ("MedGenesis"), a biopharmaceutical company developing and commercializing innovative treatments for patients with serious central nervous system (CNS) diseases, announced today that it has successfully entered into an agreement with Amgen Inc. ("Amgen"), granting MedGenesis an exclusive, worldwide license for glial cell line-derived neurotrophic factor (GDNF) protein in CNS and non-CNS indications, subject to the rights of a co-exclusive licensee for CNS indications in certain countries, as further described below.
Main Finding(s): Minority women were more likely to have aggressive subtypes of breast cancer and were more likely to receive non-guideline concordant treatment when compared with non-Hispanic white women.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Ashley M Sacks, DPT 135 S Wakea Ave Ste 112, Kahului, HI 96732-1385 Ph: (808) 280-7711 | Ashley M Sacks, DPT 135 S Wakea Ave Ste 112, Kahului, HI 96732-1385 Ph: (808) 280-7711 |
News Archive
The FDA has granted Cytori Therapeutics 510(k) marketing clearance for its PureGraft™ System. Cytori will now launch the first and only device in the United States cleared for aesthetic body contouring using autologous fat. PureGraft™ allows a patient's own fat tissue to rapidly be prepared in approximately 15 minutes for re-injection back into the same patient for aesthetic contouring.
A study led by Russell R. Russo, MD, a third-year Orthopaedic Surgery resident at LSU Health Sciences Center New Orleans School of Medicine, has identified a new source of life-threatening necrotizing fasciitis - "bath salts."
MedGenesis Therapeutix Inc. ("MedGenesis"), a biopharmaceutical company developing and commercializing innovative treatments for patients with serious central nervous system (CNS) diseases, announced today that it has successfully entered into an agreement with Amgen Inc. ("Amgen"), granting MedGenesis an exclusive, worldwide license for glial cell line-derived neurotrophic factor (GDNF) protein in CNS and non-CNS indications, subject to the rights of a co-exclusive licensee for CNS indications in certain countries, as further described below.
Main Finding(s): Minority women were more likely to have aggressive subtypes of breast cancer and were more likely to receive non-guideline concordant treatment when compared with non-Hispanic white women.
› Verified 4 days ago
Jazmine Alexis Moreno, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 335 Hoohana St Ste F, Kahului, HI 96732 Phone: 808-446-2032 | |
Sarah Dastice, PT, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 335 Hoohana St Ste F, Kahului, HI 96732 Phone: 808-446-2032 Fax: 335-653-1448 | |
Madeleine Lauer, DPT Physical Therapist Medicare: Medicare Enrolled Practice Location: 285 W Kaahumanu Ave Ste 205, Kahului, HI 96732 Phone: 808-877-4663 | |
Mrs. Angela M. Peters, MPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 135 S Wakea Ave Ste 112, Kahului, HI 96732 Phone: 808-280-7711 Fax: 808-442-0690 | |
Wailuku Physical Therapy Physical Therapist Medicare: Medicare Enrolled Practice Location: 285 W Kaahumanu Ave Ste 205, Kahului, HI 96732 Phone: 808-877-4663 Fax: 808-877-4662 | |
Dr. Flora Kay Voelker, DPT Physical Therapist Medicare: Medicare Enrolled Practice Location: 431 Alamaha St Ste A, Kahului, HI 96732 Phone: 808-667-6161 Fax: 877-664-0133 |